Skip to main content
NCBI home page
Environmental Health Perspectives logoLink to Environmental Health Perspectives
. 1987 Jun;72:283–296. doi: 10.1289/ehp.8772283

Effects of cigarette smoking on metabolic events in the lung.

S Kitamura
PMCID: PMC1474663  PMID: 3305000

Abstract

Nicotine and cigarette smoke extract show acute physiological effects: increasing tracheal pressure (PTR), pulmonary artery pressure (PPA), systemic blood pressure (PSYST), and left atrium pressure (PLA); and decreasing cardiac output (QAORTA) and blood flow to the left lower lobe (QLLL). In addition, cigarette smoking induces bronchoconstriction, thus decreasing peak flow, FVC, and FEV1.0 in healthy subjects. It has also been demonstrated that cigarette smoking caused temporary slowing of mucociliary clearance in the lung and that cigarette smoke increases the activity of aryl hydrocarbon hydroxylase which metabolizes benzo[alpha]pyrene. We demonstrated that serum angiotensin I converting enzyme (ACE) activity showed a significant increase immediately after smoking and returned to the control level 20 min after smoking. We also demonstrated that plasma histamine levels showed a marked decrease after smoking. Furthermore, the effects of cigarette smoke and related substances on prostaglandin, thromboxane, testosterone, cyclic nucleotides metabolism, and protein synthesis were also investigated.

Full text

PDF
283

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Albert R. E., Spiegelman J. R., Shatsky S., Lippmann M. The effect of acute exposure to cigarette smoke on bronchial clearance in the miniature donkey. Arch Environ Health. 1969 Jan;18(1):30–41. doi: 10.1080/00039896.1969.10665369. [DOI] [PubMed] [Google Scholar]
  2. Andersson R., Nilsson K., Wikberg J., Johansson S., Mohme-Lundholm E., Lundholm L. Cyclic nucleotides and the contraction of smooth muscle. Adv Cyclic Nucleotide Res. 1975;5:491–518. [PubMed] [Google Scholar]
  3. Arnold W. P., Aldred R., Murad F. Cigarette smoke activates guanylate cyclase and increases guanosine 3',5'-monophosphate in tissues. Science. 1977 Dec 2;198(4320):934–936. doi: 10.1126/science.22126. [DOI] [PubMed] [Google Scholar]
  4. Aviado D. M., Samanék M., Folle L. E. Cardiopulmonary effects of tobacco and related substances. I. The release of histamine during inhalation of cigarette smoke and anoxemia in the heart-lung and intact dog preparation. Arch Environ Health. 1966 Jun;12(6):705–711. doi: 10.1080/00039896.1966.10664468. [DOI] [PubMed] [Google Scholar]
  5. BENNETT A. THE METABOLISM OF HISTAMINE BY GUINEA-PIG AND RAT LUNG IN VITRO. Br J Pharmacol Chemother. 1965 Feb;24:147–155. doi: 10.1111/j.1476-5381.1965.tb02089.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. BROCKLEHURST W. E. The release of histamine and formation of a slow-reacting substance (SRS-A) during anaphylactic shock. J Physiol. 1960 Jun;151:416–435. doi: 10.1113/jphysiol.1960.sp006449. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. BROWN D. D., TOMCHICK R., AXELROD J. The distribution and properties of a histamine-methylating enzyme. J Biol Chem. 1959 Nov;234:2948–2950. [PubMed] [Google Scholar]
  8. Bakhle Y. S., Hartiala J., Toivonen H., Uotila P. Effects of cigarette smoke on the metabolism of vasoactive hormones in rat isolated lungs. Br J Pharmacol. 1979 Mar;65(3):495–499. doi: 10.1111/j.1476-5381.1979.tb07857.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Bakhle Y. S., Youdim M. B. The metabolism of 5-hydroxytryptamine and beta-phenylethylamine in perfused rat lung and in vitro. Br J Pharmacol. 1979 Jan;65(1):147–154. doi: 10.1111/j.1476-5381.1979.tb17343.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Biron P., Campeau L., David P. Fate of angiotensin I and II in the human pulmonary circulation. Am J Cardiol. 1969 Oct;24(4):544–547. doi: 10.1016/0002-9149(69)90498-6. [DOI] [PubMed] [Google Scholar]
  11. Boyes R. N., Scott D. B., Jebson P. J., Godman M. J., Julian D. G. Pharmacokinetics of lidocaine in man. Clin Pharmacol Ther. 1971 Jan-Feb;12(1):105–116. doi: 10.1002/cpt1971121105. [DOI] [PubMed] [Google Scholar]
  12. Burghuber O. C., Punzengruber C., Sinzinger H., Haber P., Silberbauer K. Platelet sensitivity to prostacyclin in smokers and non-smokers. Chest. 1986 Jul;90(1):34–38. doi: 10.1378/chest.90.1.34. [DOI] [PubMed] [Google Scholar]
  13. Cantrell E. T., Warr G. A., Busbee D. L., Martin R. R. Induction of aryl hydrocarbon hydroxylase in human pulmonary alveolar macrophages by cigarette smoking. J Clin Invest. 1973 Aug;52(8):1881–1884. doi: 10.1172/JCI107371. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Cohen A. B., Cline M. J. The human alveolar macrophage: isolation, cultivation in vitro, and studies of morphologic and functional characteristics. J Clin Invest. 1971 Jul;50(7):1390–1398. doi: 10.1172/JCI106622. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Cohen G. M., Uotila P., Hartiala J., Suolinna E. M., Simberg N., Pelkonen O. Metabolism and covalent binding of [3H]benzo(a)pyrene by isolated perfused lungs and short-term tracheal organ culture of cigarette smoke-exposed rats. Cancer Res. 1977 Jul;37(7 Pt 1):2147–2155. [PubMed] [Google Scholar]
  16. Da Silva A. M., Hamosh P. Effect of smoking a single cigarette on the "small airways". J Appl Physiol. 1973 Mar;34(3):361–365. doi: 10.1152/jappl.1973.34.3.361. [DOI] [PubMed] [Google Scholar]
  17. Dalhamn T., Rylander R. Cigarette smoke and ciliastasis. Effect of varying composition of smoke. Arch Environ Health. 1966 Jul;13(1):47–50. doi: 10.1080/00039896.1966.10664508. [DOI] [PubMed] [Google Scholar]
  18. Demarest G. B., Hudson L. D., Altman L. C. Impaired alveolar macrophage chemotaxis in patients with acute smoke inhalation. Am Rev Respir Dis. 1979 Feb;119(2):279–286. doi: 10.1164/arrd.1979.119.2.279. [DOI] [PubMed] [Google Scholar]
  19. Drath D. B., Davies P., Karnovsky M. L., Huber G. L. Tobacco smoke and the pulmonary alveolar macrophage. Adv Exp Med Biol. 1979;121(A):555–568. doi: 10.1007/978-1-4684-3593-1_46. [DOI] [PubMed] [Google Scholar]
  20. Ercan Z. S., Bökesoy T. A., Türker R. K. Role of endogenous prostaglandins on the conversion of angiotensin I to angiotensin II in the pulmonary circulation. Prostaglandins Med. 1979 May;2(5):343–352. doi: 10.1016/0161-4630(79)90107-1. [DOI] [PubMed] [Google Scholar]
  21. Essman W. B. Serotonin and monoamine oxidase in mouse skin: effects of cigarette smoke exposure. J Med. 1977;8(2):95–101. [PubMed] [Google Scholar]
  22. Fairlamb A. H., Opperdoes F. R., Borst P. New approach to screening drugs for activity against African trypanosomes. Nature. 1977 Jan 20;265(5591):270–271. doi: 10.1038/265270a0. [DOI] [PubMed] [Google Scholar]
  23. Fanburg B. L., Glazier J. B. Conversion of angiotensin 1 to angiotensin 2 in the isolated perfused dog lung. J Appl Physiol. 1973 Sep;35(3):325–331. doi: 10.1152/jappl.1973.35.3.325. [DOI] [PubMed] [Google Scholar]
  24. Ferreira S. H., Ng K. K., Vane J. R. The continuous bioassay of the release and disappearance of histamine in the circulation. Br J Pharmacol. 1973 Nov;49(3):543–553. doi: 10.1111/j.1476-5381.1973.tb17265.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Frances R., Alessandro D., Lippmann M., Proctor D. E., Albert R. E. Effect of cigarette smoke on particle transport on nasociliary mucosa on donkeys. Arch Environ Health. 1970 Jul;21(1):25–31. doi: 10.1080/00039896.1970.10667187. [DOI] [PubMed] [Google Scholar]
  26. Garrett R. J. Collagen and non-collagen protein synthesis in developing lung exposed to tobacco smoke. Environ Res. 1978 Oct;17(2):205–215. doi: 10.1016/0013-9351(78)90022-1. [DOI] [PubMed] [Google Scholar]
  27. Garrett R. J., Jackson M. A. Cigarette smoke and protein synthesis in the lung. Environ Res. 1980 Apr;21(2):399–406. doi: 10.1016/0013-9351(80)90043-2. [DOI] [PubMed] [Google Scholar]
  28. Green G. M., Carolin D. The depressant effect of cigarette smoke on the in vitro antibacterial activity of alveolar macrophages. N Engl J Med. 1967 Feb 23;276(8):421–427. doi: 10.1056/NEJM196702232760801. [DOI] [PubMed] [Google Scholar]
  29. Green G. M., Carolin D. The depressant effect of cigarette smoke on the in vitro antibacterial activity of alveolar macrophages. N Engl J Med. 1967 Feb 23;276(8):421–427. doi: 10.1056/NEJM196702232760801. [DOI] [PubMed] [Google Scholar]
  30. Green G. M. Cigarette smoke: protection of alveolar macrophages by glutathione and cysteine. Science. 1968 Nov 15;162(3855):810–811. doi: 10.1126/science.162.3855.810. [DOI] [PubMed] [Google Scholar]
  31. Hagedorn B., Kostenbauder H. B. Studies on the effect of tobacco smoke on the biotransformation of vasoactive substances in the isolated perfused rabbit lung. I. Prostaglandin F2alpha. Res Commun Chem Pathol Pharmacol. 1977 Nov;18(3):495–506. [PubMed] [Google Scholar]
  32. Hagedorn B., Kostenbauder H. B. Studies on the effect of tobacco smoke on the biotransformation of vasoactive substances in the isolated perfused rabbit lung. II. Angiotensin I conversion. Res Commun Chem Pathol Pharmacol. 1978 Apr;20(1):195–198. [PubMed] [Google Scholar]
  33. Hamberg M., Svensson J., Samuelsson B. Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides. Proc Natl Acad Sci U S A. 1975 Aug;72(8):2994–2998. doi: 10.1073/pnas.72.8.2994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Hartiala J., Uotila P., Nienstedt W. The effects of cigarette smoke exposure on testosterone metabolism in the isolated perfused rat lung. J Steroid Biochem. 1978 Apr;9(4):365–368. doi: 10.1016/0022-4731(78)90632-5. [DOI] [PubMed] [Google Scholar]
  35. Hinman L. M., Stevens C. A., Matthay R. A., Gee J. B. Elastase and lysozyme activities in human alveolar macrophages. Effects of cigarette smoking. Am Rev Respir Dis. 1980 Feb;121(2):263–271. doi: 10.1164/arrd.1980.121.2.263. [DOI] [PubMed] [Google Scholar]
  36. Hladovec J. Endothelial injury by nicotine and its prevention. Experientia. 1978 Dec 15;34(12):1585–1586. doi: 10.1007/BF02034689. [DOI] [PubMed] [Google Scholar]
  37. Hoffmann D., Hecht S. S. Nicotine-derived N-nitrosamines and tobacco-related cancer: current status and future directions. Cancer Res. 1985 Mar;45(3):935–944. [PubMed] [Google Scholar]
  38. Hoidal J. R., Fox R. B., LeMarbre P. A., Takiff H. E., Repine J. E. Oxidative metabolism of alveolar macrophages from young asymptomatic cigarette smokers. Increased superoxide anion release and its potential consequences. Chest. 1980 Feb;77(2 Suppl):270–271. doi: 10.1378/chest.77.2.270. [DOI] [PubMed] [Google Scholar]
  39. Huber G. L., Pochay V. E., Mahajan V. K., McCarthy C. R., Hinds W. C., Davies P., Drath D. B., Sornberger G. C. The effect of chronic exposure to tobacco smoke on the antibacterial defenses of the lung. Bull Eur Physiopathol Respir. 1977 Jan-Feb;13(1):145–156. [PubMed] [Google Scholar]
  40. Ishihara Y., Sugiyama Y., Kitamura S., Kosaka K., Chijimatsu Y., Homma H. [Effects of cigarette smoking on pulmonary functions and on plasma levels of serotonin, histamine and serum angiotensin I converting enzyme activity (author's transl)]. Nihon Kyobu Shikkan Gakkai Zasshi. 1981 Oct;19(10):721–727. [PubMed] [Google Scholar]
  41. Jerina D. M., Daly J. W. Arene oxides: a new aspect of drug metabolism. Science. 1974 Aug 16;185(4151):573–582. doi: 10.1126/science.185.4151.573. [DOI] [PubMed] [Google Scholar]
  42. Jones R., Reid L. Secretory cell hyperplasia and modification of intracellular glycoprotein in rat airways induced by short periods of exposure to tobacco smoke, and the effect of the antiinflammatory agent phenylmethyloxadiazole. Lab Invest. 1978 Jul;39(1):41–49. [PubMed] [Google Scholar]
  43. Junod A. F. Uptake, metabolism and efflux of 14 C-5-hydroxytryptamine in isolated perfused rat lungs. J Pharmacol Exp Ther. 1972 Nov;183(2):341–355. [PubMed] [Google Scholar]
  44. Kaliner M., Austen K. F. Cyclic nucleotides and modulation of effector systems of inflammation. Biochem Pharmacol. 1974 Feb 15;23(4):763–771. doi: 10.1016/0006-2952(74)90206-8. [DOI] [PubMed] [Google Scholar]
  45. Karhi T., Rantala A., Toivonen H. Pulmonary inactivation of 5-hydroxytryptamine is decreased during cigarette smoke ventilation of rat isolated lungs. Br J Pharmacol. 1982 Oct;77(2):245–248. doi: 10.1111/j.1476-5381.1982.tb09292.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Kensler C. J., Battista S. P. Chemical and physical factors affecting mammalian ciliary activity. Am Rev Respir Dis. 1966 Mar;93(3 Suppl):93–102. doi: 10.1164/arrd.1966.93.3P2.93. [DOI] [PubMed] [Google Scholar]
  47. Kitamura S., Ishihara Y., Sugiyama Y., Izumi T., Hayashi R., Hsu L. H., Kosaka K., Harasawa M. [Angiotensin I converting enzyme activity in patients with spontaneous pneumothorax and in rabbits with artificial pneumothorax (author's transl)]. Nihon Kyobu Shikkan Gakkai Zasshi. 1981 Sep;19(9):619–623. [PubMed] [Google Scholar]
  48. Klass D. J. Cigarette smoke exposure in vivo increases cyclic GMP in rat lung. Arch Environ Health. 1980 Nov-Dec;35(6):347–350. doi: 10.1080/00039896.1980.10667518. [DOI] [PubMed] [Google Scholar]
  49. LILJA B., LINDELL S. E., SALDEEN T. Formation and destruction of C14 histamine in human lung tissue in vitro. J Allergy. 1960 Nov-Dec;31:492–496. doi: 10.1016/0021-8707(60)90083-6. [DOI] [PubMed] [Google Scholar]
  50. Levine P. H. An acute effect of cigarette smoking on platelet function. A possible link between smoking and arterial thrombosis. Circulation. 1973 Sep;48(3):619–623. doi: 10.1161/01.cir.48.3.619. [DOI] [PubMed] [Google Scholar]
  51. Lieberman J. Elevation of serum angiotensin-converting-enzyme (ACE) level in sarcoidosis. Am J Med. 1975 Sep;59(3):365–372. doi: 10.1016/0002-9343(75)90395-2. [DOI] [PubMed] [Google Scholar]
  52. MUSTARD J. F., MURPHY E. A. Effect of smoking on blood coagulation and platelet survival in man. Br Med J. 1963 Mar 30;1(5334):846–849. doi: 10.1136/bmj.1.5334.846. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Mann P. E., Cohen A. B., Finley T. N., Ladman A. J. Alveolar macrophages. Structural and functional differences between nonsmokers and smokers of marijuana and tobacco. Lab Invest. 1971 Aug;25(2):111–120. [PubMed] [Google Scholar]
  54. Martin R. R. Altered morphology and increased acid hydrolase content of pulmonary macrophages from cigarette smokers. Am Rev Respir Dis. 1973 Apr;107(4):596–601. doi: 10.1164/arrd.1973.107.4.596. [DOI] [PubMed] [Google Scholar]
  55. Matulionis D. H., Traurig H. H. In situ response of lung macrophages and hydrolase activities to cigarette smoke. Lab Invest. 1977 Sep;37(3):314–326. [PubMed] [Google Scholar]
  56. McGovren J. P., Lubawy W. C., Kostenbauder H. B. Uptake and metabolism of nicotine by the isolated perfused rabbit lung. J Pharmacol Exp Ther. 1976 Oct;199(1):198–207. [PubMed] [Google Scholar]
  57. Miller J. A. Carcinogenesis by chemicals: an overview--G. H. A. Clowes memorial lecture. Cancer Res. 1970 Mar;30(3):559–576. [PubMed] [Google Scholar]
  58. Mittal C. K., Murad F. Properties and oxidative regulation of guanylate cyclase. J Cyclic Nucleotide Res. 1977 Dec;3(6):381–391. [PubMed] [Google Scholar]
  59. Molteni A., Zakheim R. M., Mullis K. B., Mattioli L. The effect of chronic alveolar hypoxia on lung and serum angiotensin I converting enzyme activity. Proc Soc Exp Biol Med. 1974 Oct;147(1):263–265. doi: 10.3181/00379727-147-38323. [DOI] [PubMed] [Google Scholar]
  60. Moncada S., Gryglewski R., Bunting S., Vane J. R. An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature. 1976 Oct 21;263(5579):663–665. doi: 10.1038/263663a0. [DOI] [PubMed] [Google Scholar]
  61. Ng K. K., Vane J. R. Fate of angiotensin I in the circulation. Nature. 1968 Apr 13;218(5137):144–150. doi: 10.1038/218144a0. [DOI] [PubMed] [Google Scholar]
  62. Okamoto T., Chan P. C., So B. T. Effect of tobacco, marijuana and benzo(a)pyrene on aryl hydrocarbon hydroxylase in hamster lung. Life Sci II. 1972 Aug 8;11(15):733–741. doi: 10.1016/0024-3205(72)90068-9. [DOI] [PubMed] [Google Scholar]
  63. Oparil S., Low J., Koerner T. J. Altered angiotensin I conversion in pulmonary disease. Clin Sci Mol Med. 1976 Dec;51(6):537–543. doi: 10.1042/cs0510537. [DOI] [PubMed] [Google Scholar]
  64. Pavia D., Thomson M. L., Pocock S. J. Evidence for temporary slowing of mucociliary clearance in the lung caused by tobacco smoking. Nature. 1971 Jun 4;231(5301):325–326. doi: 10.1038/231325a0. [DOI] [PubMed] [Google Scholar]
  65. Piper P. J., Vane J. R. Release of additional factors in anaphylaxis and its antagonism by anti-inflammatory drugs. Nature. 1969 Jul 5;223(5201):29–35. doi: 10.1038/223029a0. [DOI] [PubMed] [Google Scholar]
  66. Rasp F. L., Clawson C. C., Hoidal J. R., Repine J. E. Reversible impairment of the adherence of alveolar macrophages from cigarette smokers. Am Rev Respir Dis. 1978 Dec;118(6):979–986. doi: 10.1164/arrd.1978.118.6.979. [DOI] [PubMed] [Google Scholar]
  67. Reynolds H. Y., Newball H. H. Analysis of proteins and respiratory cells obtained from human lungs by bronchial lavage. J Lab Clin Med. 1974 Oct;84(4):559–573. [PubMed] [Google Scholar]
  68. Rodriguez R. J., White R. R., Senior R. M., Levine E. A. Elastase release from human alveolar macrophages: comparison between smokers and nonsmokers. Science. 1977 Oct 21;198(4314):313–314. doi: 10.1126/science.910131. [DOI] [PubMed] [Google Scholar]
  69. Roque A. L., Pickren J. W. Enzymatic changes in fluorescent alveolar macrophages of the lungs of cigarette smokers. Acta Cytol. 1968 Nov-Dec;12(6):420–429. [PubMed] [Google Scholar]
  70. Rowland M., Riegelman S., Harris P. A., Sholkoff S. D. Absorption kinetics of aspirin in man following oral administration of an aqueous solution. J Pharm Sci. 1972 Mar;61(3):379–385. doi: 10.1002/jps.2600610312. [DOI] [PubMed] [Google Scholar]
  71. Ryan J. W., Ryan U. S. Pulmonary endothelial cells. Fed Proc. 1977 Dec;36(13):2683–2691. [PubMed] [Google Scholar]
  72. Rylander R. Free lung cell studies in cigarette smoke inhalation experiments. Scand J Respir Dis. 1971;52(2):121–128. [PubMed] [Google Scholar]
  73. Rylander R. Lung clearance of particles and bacteria. Effects of cigarette smoke exposure. Arch Environ Health. 1971 Nov;23(5):321–326. doi: 10.1080/00039896.1971.10666016. [DOI] [PubMed] [Google Scholar]
  74. SCHAYER R. W. The metabolism of histamine in various species. Br J Pharmacol Chemother. 1956 Dec;11(4):472–473. doi: 10.1111/j.1476-5381.1956.tb00020.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  75. SCHILD H. O., HAWKINS D. F., MONGAR J. L., HERXHEIMER H. Reactions of isolated human asthmatic lung and bronchial tissue to a specific antigen; histamine release and muscular contraction. Lancet. 1951 Sep 1;2(6679):376–382. doi: 10.1016/s0140-6736(51)91554-1. [DOI] [PubMed] [Google Scholar]
  76. SOMA L. R., PENNA M., AVIADO D. M. MECHANISMS FOR CARDIAC STIMULATION DURING ANOXEMIA IN THE MODIFIED HEART-LUNG PREPARATIONS. Pflugers Arch Gesamte Physiol Menschen Tiere. 1965;282:209–224. doi: 10.1007/BF00412709. [DOI] [PubMed] [Google Scholar]
  77. Saba S. R., Mason R. G. Some effects of nicotine on platelets. Thromb Res. 1975 Nov;7(5):819–824. doi: 10.1016/0049-3848(75)90207-8. [DOI] [PubMed] [Google Scholar]
  78. Said S. I. Metabolic functions of the pulmonary circulation. Circ Res. 1982 Mar;50(3):325–333. doi: 10.1161/01.res.50.3.325. [DOI] [PubMed] [Google Scholar]
  79. Said S. I., Yoshida T., Kitamura S., Vreim C. Pulmonary alveolar hypoxia: release of prostaglandins and other humoral mediators. Science. 1974 Sep 27;185(4157):1181–1183. doi: 10.1126/science.185.4157.1181. [DOI] [PubMed] [Google Scholar]
  80. Sanders C. L., Jackson T. A., Adee R. R., Powers G. J., Wehner A. P. Distribution of inhaled metal oxide particles in pulmonary alveoli. Arch Intern Med. 1971 Jun;127(6):1085–1089. [PubMed] [Google Scholar]
  81. Schayer R. W., Reilly M. A. Histamine catabolism in guinea pigs, rats and mice. Eur J Pharmacol. 1974 Jan;25(1):101–107. doi: 10.1016/0014-2999(74)90100-9. [DOI] [PubMed] [Google Scholar]
  82. Seifert W. E., Rudland P. S. Possible involvement of cyclic GMP in growth control of cultured mouse cells. Nature. 1974 Mar 8;248(5444):138–140. doi: 10.1038/248138a0. [DOI] [PubMed] [Google Scholar]
  83. Simberg N., Uotila P. Stimulatory effect of cigarette smoke on the metabolism and covalent binding of benzo(a)pyrene in the trachea of the rat. Int J Cancer. 1978 Jul 15;22(1):28–31. doi: 10.1002/ijc.2910220107. [DOI] [PubMed] [Google Scholar]
  84. Sims P., Grover P. L. Epoxides in polycyclic aromatic hydrocarbon metabolism and carcinogenesis. Adv Cancer Res. 1974;20:165–274. doi: 10.1016/s0065-230x(08)60111-6. [DOI] [PubMed] [Google Scholar]
  85. Steinberg H., Bassett D. J., Fisher A. B. Depression of pulmonary 5-hydroxytryptamine uptake by metabolic inhibitors. Am J Physiol. 1975 May;228(5):1298–1303. doi: 10.1152/ajplegacy.1975.228.5.1298. [DOI] [PubMed] [Google Scholar]
  86. Sugiyama Y., Ishihara Y., Kitamura S., Kosaka K., Chijimatsu Y., Honma H. [Smoking and lung metabolism -effects on nicotine injection on the canine airway, pulmonary and systemic circulation (author's transl)]. Nihon Kyobu Shikkan Gakkai Zasshi. 1982 Mar;20(3):317–322. [PubMed] [Google Scholar]
  87. Thithapandha A. Substrate specificity and heterogeneity of N-methyltransferases. Biochem Biophys Res Commun. 1972 Apr 28;47(2):301–308. doi: 10.1016/0006-291x(72)90712-7. [DOI] [PubMed] [Google Scholar]
  88. Thomas W. R., Holt P. G., Keast D. Cigarette smoke and phagocyte function: effect of chronic exposure in vivo and acute exposure in vitro. Infect Immun. 1978 May;20(2):468–475. doi: 10.1128/iai.20.2.468-475.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  89. Turner D. M., Armitage A. K., Briant R. H., Dollery C. T. Metabolism of nicotine by the isolated perfused dog lung. Xenobiotica. 1975 Sep;5(9):539–551. doi: 10.3109/00498257509056124. [DOI] [PubMed] [Google Scholar]
  90. Uotila P., Pelkonen O., Cohen G. M. The effects of cigarette smoke on the metabolism of [3H]benzo(a)pyrene by rat lung microsomes. Cancer Res. 1977 Jul;37(7 Pt 1):2156–2161. [PubMed] [Google Scholar]
  91. Vargaftig B. B., Hai N. D. Selective inhibition by mepacrine of the release of "rabbit aorta contracting substance" evoked by the administration of bradykinin. J Pharm Pharmacol. 1972 Feb;24(2):159–161. doi: 10.1111/j.2042-7158.1972.tb08953.x. [DOI] [PubMed] [Google Scholar]
  92. Vesely D. L., Levey G. S. Hydrazine activation of guanylate cyclase: potential application to tobacco carcinogenesis. Biochem Biophys Res Commun. 1977 Jan 24;74(2):780–784. doi: 10.1016/0006-291x(77)90370-9. [DOI] [PubMed] [Google Scholar]
  93. Warr G. A., Martin R. R. Chemotactic responsiveness of human alveolar macrophages: effects of cigarette smoking. Infect Immun. 1974 Apr;9(4):769–771. doi: 10.1128/iai.9.4.769-771.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  94. Welch R. M., Loh A., Conney A. H. Cigarette smoke: stimulatory effect of metabolism of 3,4--benzpyrene by enzymes in rat lung. Life Sci I. 1971 Feb 15;10(4):215–221. doi: 10.1016/0024-3205(71)90250-5. [DOI] [PubMed] [Google Scholar]
  95. Wennmalm A. Nicotine inhibits the release of 6-keto-prostaglandin F1alpha from the isolated perfused rabbit heart. Acta Physiol Scand. 1978 May;103(1):107–109. doi: 10.1111/j.1748-1716.1978.tb06196.x. [DOI] [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Sciences

RESOURCES